12/23/2020 | Sponsored by Allergan
DURYSTA™ is indicated for the reduction of IOP in patients with open angle glaucoma or ocular hypertension
09/07/2019 | Sponsored by Allergan
The winners of the ICO-Allergan Advanced Research Fellowship… in conversation.
07/31/2019 | Sponsored by Allergan
Matias Iglicki has been awarded a $50,000 research grant by the ICO-Allergan program
06/13/2019 | Sponsored by Allergan
Introducing the winner of the ICO-Allergan Advanced Research Fellowship 2019
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Landmark nAMD Treatment
Verifying Your Vision and Values
Pushing Back on BAK
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: